PH13669A - 6-nor-6-isopropyl-9,10-dihydro-2'beta-methyl-5'alpha-benzyl-ergopetine - Google Patents

6-nor-6-isopropyl-9,10-dihydro-2'beta-methyl-5'alpha-benzyl-ergopetine

Info

Publication number
PH13669A
PH13669A PH16563A PH16563A PH13669A PH 13669 A PH13669 A PH 13669A PH 16563 A PH16563 A PH 16563A PH 16563 A PH16563 A PH 16563A PH 13669 A PH13669 A PH 13669A
Authority
PH
Philippines
Prior art keywords
ergopetine
dihydro
beta
benzyl
isopropyl
Prior art date
Application number
PH16563A
Other languages
English (en)
Inventor
P Stadler
T Fehr
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of PH13669A publication Critical patent/PH13669A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/02—Ergot alkaloids of the cyclic peptide type

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PH16563A 1973-11-28 1974-11-26 6-nor-6-isopropyl-9,10-dihydro-2'beta-methyl-5'alpha-benzyl-ergopetine PH13669A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1669873A CH587858A5 (fr) 1973-11-28 1973-11-28

Publications (1)

Publication Number Publication Date
PH13669A true PH13669A (en) 1980-08-26

Family

ID=4419482

Family Applications (1)

Application Number Title Priority Date Filing Date
PH16563A PH13669A (en) 1973-11-28 1974-11-26 6-nor-6-isopropyl-9,10-dihydro-2'beta-methyl-5'alpha-benzyl-ergopetine

Country Status (25)

Country Link
US (1) US4229451A (fr)
JP (1) JPS5919116B2 (fr)
AT (1) AT352911B (fr)
BE (1) BE822729A (fr)
CA (1) CA1034572A (fr)
CH (1) CH587858A5 (fr)
CS (1) CS176291B2 (fr)
DD (1) DD115119A5 (fr)
DE (1) DE2454619A1 (fr)
DK (1) DK143804C (fr)
ES (1) ES432288A1 (fr)
FI (1) FI59254C (fr)
FR (2) FR2252098B1 (fr)
GB (2) GB1496491A (fr)
HK (1) HK54080A (fr)
HU (1) HU168859B (fr)
IE (1) IE41767B1 (fr)
IL (1) IL46128A (fr)
MY (1) MY8100185A (fr)
NL (1) NL7415250A (fr)
NO (1) NO744175L (fr)
PH (1) PH13669A (fr)
SE (2) SE417319B (fr)
SU (1) SU516355A3 (fr)
ZA (1) ZA747603B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH601321A5 (fr) * 1975-01-06 1978-07-14 Sandoz Ag
CH619468A5 (fr) * 1976-01-12 1980-09-30 Sandoz Ag
DE3020895A1 (de) * 1979-06-12 1980-12-18 Sandoz Ag Ergopeptinderivate, verfahren zu deren herstellung sowie diese ergopeptinderivate enthaltende pharmazeutischen zusammensetzungen
US5069911A (en) * 1985-02-05 1991-12-03 Sandoz Ltd. Pharmaceutical 9,10-dihydrogenated ergot alkaloid containing compositions
US7771746B2 (en) * 1999-12-03 2010-08-10 Polichem Sa Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
GB0409785D0 (en) * 2004-04-30 2004-06-09 Resolution Chemicals Ltd Preparation of cabergoline
US7339060B2 (en) 2005-03-23 2008-03-04 Resolution Chemicals, Ltd. Preparation of cabergoline
GB0505965D0 (en) * 2005-03-23 2005-04-27 Resolution Chemicals Ltd Preparation of cabergoline
US20070197576A1 (en) * 2006-02-08 2007-08-23 Resolution Chemicals Limited Production of Cabergoline and Novel Polymorphic Form Thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2619488A (en) * 1952-11-25 Method of preparing d
GB769260A (en) * 1954-04-07 1957-03-06 Sandoz Ltd Process for the preparation of isomeric racemic dihydrolysergic acids and their homologues
DE1006425B (de) * 1954-04-07 1957-04-18 Sandoz Ag Verfahren zur Herstellung der isomeren racemischen Dihydrolysergsaeuren und ihren Homologen
GB1011112A (en) * 1961-05-10 1965-11-24 Sandoz Ag Improvements in or relating to ergot alkaloids
CH469006A (de) * 1965-07-07 1969-02-28 Sandoz Ag Verfahren zur Herstellung neuer synthetischer Alkaloide
CH469735A (de) * 1965-11-02 1969-03-15 Sandoz Ag Verfahren zur Herstellung heterocyclischer Verbindungen
GB1298277A (en) * 1969-04-18 1972-11-29 Sandoz Ltd Preparation of ergot peptide alkaloids
CH534683A (de) * 1970-05-26 1973-03-15 Sandoz Ag Verfahren zur Herstellung neuer Mutterkornpeptidalkaloide
CH601321A5 (fr) * 1975-01-06 1978-07-14 Sandoz Ag
US4138565A (en) * 1975-05-31 1979-02-06 Sandoz Ltd. Stable solutions and processes for their preparation

Also Published As

Publication number Publication date
SE424869B (sv) 1982-08-16
GB1496492A (en) 1977-12-30
ZA747603B (en) 1976-07-28
DE2454619A1 (de) 1975-06-05
HK54080A (en) 1980-10-03
NO744175L (fr) 1975-06-23
SU516355A3 (ru) 1976-05-30
MY8100185A (en) 1981-12-31
FR2252098B1 (fr) 1978-06-30
DK600374A (fr) 1975-07-28
FR2334681A1 (fr) 1977-07-08
FI59254B (fi) 1981-03-31
CH587858A5 (fr) 1977-05-13
ATA945174A (de) 1979-03-15
IL46128A (en) 1977-10-31
DK143804C (da) 1982-03-29
IE41767L (en) 1975-05-28
FR2334681B1 (fr) 1980-04-18
ES432288A1 (es) 1977-02-16
IE41767B1 (en) 1980-03-26
SE7414607L (fr) 1975-05-29
AU7582674A (en) 1976-05-27
HU168859B (fr) 1976-07-28
SE7710418L (sv) 1977-09-16
NL7415250A (nl) 1975-05-30
FR2252098A1 (fr) 1975-06-20
JPS5919116B2 (ja) 1984-05-02
DK143804B (da) 1981-10-12
SE417319B (sv) 1981-03-09
AT352911B (de) 1979-10-10
IL46128A0 (en) 1975-02-10
US4229451A (en) 1980-10-21
FI59254C (fi) 1981-07-10
DD115119A5 (fr) 1975-09-12
GB1496491A (en) 1977-12-30
CA1034572A (fr) 1978-07-11
FI334574A (fr) 1975-05-29
JPS5084599A (fr) 1975-07-08
BE822729A (fr) 1975-05-28
CS176291B2 (fr) 1977-06-30

Similar Documents

Publication Publication Date Title
PH11009A (en) Triazolyl-o,n-acetals
IL46162A (en) 2-acyl-4-oxo-hexahydro-4h-pyrazino-(2,1- )-isoquinolines
IE39302L (en) 1,4- diazacycloheptanes.
PH10755A (en) 5-acetamido-2,4,-dimethyltrifluoromethane-sulphonanilide
IL45654A0 (en) "triazolopyridazines"
IL45096A0 (en) The preparation of 2,2,6,6-tetramethyl-4-oxopiperidine
IL45095A0 (en) The preparation of 2,2,6,6-tetramethyl-4-oxopiperidine
MY8100330A (en) 1,3-diketo-1,2,3,4-tetrahydrosoquinolines
IL45114A (en) 3-substituted 5,5-diphenylhydantoins
IL45259A0 (en) 1,3-oxygenated 8alpha-oestratrienes
GB1482285A (en) 1,3-oxygenated 8alpha-oestratrienes
ZA744478B (en) 1,3-oxygenated 8alpha-oestratrienes
AU6850574A (en) 1,3-benzodioxole-2-carboxylic acid
PH13669A (en) 6-nor-6-isopropyl-9,10-dihydro-2'beta-methyl-5'alpha-benzyl-ergopetine
IL45092A0 (en) The preparation of 2,2,6,6-tetramethyl-4-oxopiperidine
AU7278974A (en) 2,3-dihydrobenzofuranyl-7-n-methylcarbamates
ZA744364B (en) 4,3-dihydro-2h-naphthalin-1-one-5-oxypropyl-piperazine derivatives
PH10776A (en) 2-phenylamino-imidazolines-(2)
AU6558474A (en) 7-alkyl-delta 3,5-steroids
ZA743304B (en) 17beta-hydroxy-16,16-dimethylestr-4-en-3-one
IL44783A0 (en) Novel 1,2,3-triazole derivatives
IE40060L (en) 1,5- and 1,8-dinitroanthraquinones
AU6776774A (en) 2,3-dhydro-benzofurans
AU7271274A (en) 1,2-oxaphospholanes
AU6593074A (en) 1, 4-dihydro-2-h-isoquinoline